QUOTED. Jan. 15, 2019. Namal Nawana.
The new CEO of Smith & Nephew, Namal Nawana, sat down with Medtech Insight during the JP Morgan Healthcare Conference to discuss his plans for putting the British medical giant on track for growth. See what he had to say here about the company's M&A strategy.
"We’re just constantly evaluating what makes sense to us and what doesn’t. Because sometimes there’s a strategic fit, but the value is not right; and sometimes the value might be interesting, but it’s really not close enough to what we do to be interested. But M&A is going to be a very important way forward for us going forward." –Namal Nawana, CEO, Smith & Nephew
Click here for a free trial of Medtech Insight